FDA Approves Olumiant for Adolescents with Severe Alopecia Areata
FDA approves Olumiant (baricitinib) for patients aged 12 and older with severe…
UAE and Moderna Explore Pharmaceutical Investment and Cooperation
The UAE and Moderna have explored investment and cooperation opportunities in pharmaceutical…
UAE Advances Local Manufacturing of Critical Oncology Medicines
ADCAN Pharma partners with Pinnacle Life Science to license 12 oncology products…
U.S. FDA Approves XFG-Adapted COVID-19 Vaccine for 2026โ2027
U.S. FDA approves the XFG-adapted 2026โ2027 COVID-19 vaccine from Pfizer and BioNTech…
Saudi Arabia and France Sign Agreement to Strengthen Health Cooperation
Saudi Arabia and France sign an MoU to strengthen health cooperation in…
DUPHAT 2026 to Highlight Dubaiโs Growing Role in Global Pharmaceuticals
DUPHAT 2026 will bring 25,000 visitors and 1,100 brands to Dubai, highlighting…
$80.5 Million Public Offering to Fund Development of Investigational Cancer Treatment
An $80.5 million public offering will support clinical trials, manufacturing and development…
Biotech Collaboration Aims to Advance Personalized Brain Cancer Therapy in Saudi Arabia
Northwest Biotherapeutics and SPIMACO have signed an MoU to explore the approval,…
Hikma Reports Strong H1 2026 Results, Reaffirms Full-Year Outlook
Hikma Pharmaceuticals reported 4% revenue growth to $1.728 billion in H1 2026,…
Major Acquisition to Advance Therapies for Treatment-Resistant Depression
Lilly will acquire AtaiBeckley in a deal valued at up to $3.8…
